AngioDynamics, Inc. (ANGO)
NASDAQ: ANGO · IEX Real-Time Price · USD
6.08
+0.29 (5.01%)
At close: May 2, 2024, 4:00 PM
6.25
+0.17 (2.80%)
After-hours: May 2, 2024, 5:25 PM EDT

AngioDynamics Revenue

AngioDynamics had revenue of $324.01M in the twelve months ending February 29, 2024, down -3.19% year-over-year. Revenue in the quarter ending February 29, 2024 was $75.18M, a -6.85% decrease year-over-year. In the fiscal year ending May 31, 2023, AngioDynamics had annual revenue of $338.75M with 7.13% growth.

Revenue (ttm)
$324.01M
Revenue Growth
-3.19%
P/S Ratio
0.75
Revenue / Employee
$397,556
Employees
815
Market Cap
243.53M USD

Revenue Chart

History

Fiscal Year End Revenue Change Growth
May 31, 2023338.75M22.53M7.13%
May 31, 2022316.22M25.21M8.66%
May 31, 2021291.01M26.85M10.17%
May 31, 2020264.16M-6.48M-2.39%
May 31, 2019270.63M8.98M3.43%
May 31, 2018261.66M-8.13M-3.01%
May 31, 2017269.79M-84.10M-23.77%
May 31, 2016353.89M-2.64M-0.74%
May 31, 2015356.53M2.11M0.60%
May 31, 2014354.43M12.51M3.66%
May 31, 2013341.92M120.00M54.07%
May 31, 2012221.92M6.17M2.86%
May 31, 2011215.75M-285.00K-0.13%
May 31, 2010216.04M20.98M10.76%
May 31, 2009195.05M28.55M17.15%
May 31, 2008166.50M54.27M48.36%
Jun 2, 2007112.23M33.78M43.05%
Jun 3, 200678.45M18.16M30.12%
May 28, 200560.29M11.23M22.90%
May 29, 200449.06M10.62M27.63%
May 31, 200338.43M7.54M24.42%
Jun 1, 200230.89M7.50M32.06%
Jun 2, 200123.39M--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Coherus BioSciences 257.24M
Puma Biotechnology 235.64M
2seventy bio 100.39M
AVITA Medical 51.57M
Foghorn Therapeutics 34.16M
Adlai Nortye 5.00M
Actinium Pharmaceuticals 81.00K
Revenue Rankings